Background: Calcium Channel Blockers (CCBs) are widely used in the treatment of cardiovascular
and ischemic heart diseases in recent years. They treat arrhythmias by reducing cardiac cycle
contraction and also benefit ischemic heart diseases. Electroanalytical methods are very powerful
analytical methods used in the pharmaceutical industry because of the determination of therapeutic
agents and/or their metabolites in clinical samples at extremely low concentrations (10-50 ng/ml). The
purpose of this review is to gather electroanalytical methods used for the determination of calcium
channel blocker drugs in pharmaceutical dosage forms and biological media selected mainly from current
Methods: This review mainly includes recent determination studies of calcium channel blockers by
electroanalytical methods from pharmaceutical dosage forms and biological samples. The studies of
calcium channel blockers electroanalytical determination in the literature were reviewed and interpreted.
Results: There are a lot of studies on amlodipine and nifedipine, but the number of studies on benidipine,
cilnidipine, felodipine, isradipine, lercanidipine, lacidipine, levamlodipine, manidipine,
nicardipine, nilvadipine, nimodipine, nisoldipine, nitrendipine, diltiazem, and verapamil are limited in
the literature. In these studies, DPV and SWV are the most used methods. The other methods were
used less for the determination of calcium channel blocker drugs.
Conclusion: Electroanalytical methods especially voltammetric methods supply reproducible and reliable
results for the analysis of the analyte. These methods are simple, more sensitive, rapid and inexpensive
compared to the usually used spectroscopic and chromatographic methods.